Carlo Messina

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 9

Top Topics

Locally Advanced

Benign Prostatic Hyperplasia

Radical Prostatectomy

Liver Metastases

Top Venues

Breast cancer research and treatment

Cancer management and research

European journal of clinical investigation

This page only lists publications with an associated author ORCID identifier.

Publications

Sara Mokbel, Giuilia Baciarello, Pernelle Lavaud, Aurelius Omlin, Fabio Calabrò, Richard Cathomas, Stefanie Aeppli, Pauline Parent, Patrizia Giannatempo, Kira-Lee Koster, Naara Appel, Philippe Gonnet, Gesuino Angius, Petros K Tsantoulis, Hendrick-Tobias Arkenau, Carlo Cattrini, Carlo Messina, Jean Zeghondy, Cristina Morelli, Yohann Loriot, Vincenzo Formica, Anna Patrikidou
Development and Validation of an Inflammatory Prognostic Index to Predict Outcomes in Advanced/Metastatic Urothelial Cancer Patients Receiving Immune Checkpoint Inhibitors. Cancers 16 (8) (2024)
Sara Mokbel, Giuilia Baciarello, Pernelle Lavaud, Aurelius Omlin, Fabio Calabrò, Richard Cathomas, Stefanie Aeppli, Pauline Parent, Patrizia Giannatempo, Kira-Lee Koster, Naara Appel, Philippe Gonnet, Gesuino Angius, Petros K Tsantoulis, Hendrick-Tobias Arkenau, Carlo Cattrini, Carlo Messina, Jean Zeghondy, Cristina Morelli, Yohann Loriot, Vincenzo Formica, Anna Patrikidou
Development and Validation of an Inflammatory Prognostic Index to Predict Outcomes in Advanced/Metastatic Urothelial Cancer Patients Receiving Immune Checkpoint Inhibitors. Cancers 16 (8) (2024)
Massimiliano Salati, Luigi Marcheselli, Carlo Messina, Valeria Merz, Marco Messina, Pietro Carotenuto, Francesco Caputo, Fabio Gelsomino, Andrea Spallanzani, Luca Reggiani Bonetti, Stefania Caramaschi, Gabriele Luppi, Massimo Dominici, Michele Ghidini
Development and Multicentre Validation of the Modena Score to Predict Survival in Advanced Biliary Cancers Undergoing Second-Line Chemotherapy. Cancer management and research 14 (2022)
Carlo Messina, Massimiliano Salati, Marco Messina, Carlo Cattrini, Valeria Merz, Orazio Caffo
Efficacy and safety of PD1/PDL1 blockade with platinum-based chemotherapy for extensive small cell lung cancer: A pooled analysis of randomized trials. European journal of clinical investigation 51 (5) (2021)
Pasquale Rescigno, Bora Gurel, Rita Pereira, Mateus Crespo, Jan Rekowski, Mattia Rediti, Maialen Barrero, Joaquin Mateo, Diletta Bianchini, Carlo Messina, Maria D Fenor de la Maza, Khobe Chandran, Juliet Carmichael, Christina Guo, Alec Paschalis, Adam Sharp, George Seed, Ines Figueiredo, Maryou Lambros, Susana Miranda, Ana Ferreira, Claudia Bertan, Ruth Riisnaes, Nuria Porta, Wei Yuan, Suzanne Carreira, Johann S de Bono
Characterizing CDK12-Mutated Prostate Cancers. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (2) (2020)
Carlo Cattrini, Davide Soldato, Alessandra Rubagotti, Linda Zinoli, Elisa Zanardi, Paola Barboro, Carlo Messina, Elena Castro, David Olmos, Francesco Boccardo
Epidemiological Characteristics and Survival in Patients with De Novo Metastatic Prostate Cancer. Cancers 12 (10) (2020)
Valeria Merz, Alessandro Cavaliere, Carlo Messina, Massimiliano Salati, Camilla Zecchetto, Simona Casalino, Michele Milella, Orazio Caffo, Davide Melisi
Multicenter Retrospective Analysis of Second-Line Therapy after Gemcitabine Plus Nab-Paclitaxel in Advanced Pancreatic Cancer Patients. Cancers 12 (5) (2020)
Carlo Messina, Carlo Cattrini, Giulia Buzzatti, Luigi Cerbone, Elisa Zanardi, Marco Messina, Francesco Boccardo
CDK4/6 inhibitors in advanced hormone receptor-positive/HER2-negative breast cancer: a systematic review and meta-analysis of randomized trials. Breast cancer research and treatment 172 (1) (2018)
Mattia Rediti, Carlo Messina
Towards treatment personalisation in triple negative breast cancer: role of platinum-based neoadjuvant chemotherapy. Breast cancer research and treatment 172 (1) (2018)